Picard Medical Faces Securities Fraud Lawsuit
Analysis based on 26 articles · First reported Feb 04, 2026 · Last updated Mar 11, 2026
The market is negatively impacted by the news of a securities fraud lawsuit against Picard Medical, Inc., potentially leading to a decline in its stock price and investor confidence. This event highlights the risks associated with fraudulent stock promotion schemes.
Picard Medical, Inc. is facing a securities fraud lawsuit filed by Glancy Prongay & Rotter on behalf of investors. The lawsuit alleges that between September 2, 2025, and October 31, 2025, Picard Medical, Inc. was involved in a fraudulent stock promotion scheme using social media misinformation and impersonated financial professionals. Insiders and/or affiliates are accused of using offshore or nominee accounts to dump shares during a price inflation campaign. The complaint further states that Picard Medical, Inc.'s public statements and risk disclosures failed to mention these false rumors and artificial trading activities, making their positive statements about the company's business, operations, and prospects materially misleading.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard